The disclosure relates to a nucleic acid having an Apoptotic Sequence of: Seq. ID. No:1, Seq. ID. No:2, Seq. ID. No:3, Seq. ID. No:4, Seq. ID. No: 5, Seq. ID. No:6, and Seq. ID. No:7. It also relates to a compsoition including a nucleic acid having an Apoptotic Sequence of Seq. ID. No:1, Seq. ID. No:2, Seq. ID. No:3, Seq. ID. No:4, Seq. ID. No: 5, Seq. ID. No:6, and Seq. ID. No:7. The composition may also include a pharmaceutically acceptable carrier. The disclosure also includes a method of killing a cancer cell by administering to a cancer cell a serum including a nucleic acid having an Apoptotic Sequence of: Seq. ID. No:1, Seq. ID. No:2, Seq. ID. No:3, Seq. ID. No:4, Seq. ID. No: 5, Seq. ID. No:6, and Seq. ID. No:7 and a pharmaceutically acceptable carrier. The cancer cell may be located in a subject with cancer.

 
Web www.patentalert.com

< DNA for encoding D-hydantoin hydrolases, DNA for encoding N-carbamyl-D-amino acid hydrolases, recombinant DNA containing the genes, cells transformed with the recombinant DNA, methods for producing proteins utilizing the transformed cells and methods for producing D-amino acids

< Production method of 2'-deoxyguanosine compound

> Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors

> Materials and methods for the modification of plant lignin content
~ 00283